List of directors and their roles and functions
Filed with HKEX · Stock code 2592 · · 2 pages · English
Summary by 6ix AI
This filing is a list of directors and their roles for Cloudbreak Pharma, Inc. It details the executive, non-executive, and independent non-executive directors of the company.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Cloudbreak Pharma, Inc. on 6ix
Earlier from Cloudbreak Pharma
- Appointment of independent non-executive directors and continued suspension of trading
- Business updates and supplemental announcement in relation to 2025 annual report
- Suspension of trading
- Cloudbreak Pharma Announces Results of First-of-Its-Kind Patient Survey on Pinguecula, Confirming Significant Unmet Need and Impact on Quality of Life
- Cloudbreak Pharma Announces Final Patient Visit for 12-Month Efficacy Endpoint in Phase 3 Study of CBT-001 as a Potential Treatment for Pterygium
Later from Cloudbreak Pharma
- Formation of an independent Special committee; delay in publication and despatch of 2026 interim report; and continued suspension of trading
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
- Voluntary announcement - business update in relation to the topline results from the Phase 3 study of CBT-001 in patients with pterygium
Follow Cloudbreak Pharma into a list and get an email when it puts out news.
Follow Cloudbreak Pharma